Euroimmun产品代理

产品分类 > 科研试剂 > Euroimmun产品代理

Euroimmun产品代理

作为全球领先的医学实验室诊断制造商之一,EUROIMMUN 代表着创新。 17 个国家/地区的 3,200 多名员工开发、生产和销售用于支持疾病诊断的测试系统,以及用于执行和评估这些测试的软件和自动化解决方案。 140 多个国家/地区的实验室使用 EUROIMMUN 产品来诊断自身免疫性疾病和传染病以及过敏症,并进行基因分析。
该公司于 1987 年从吕贝克大学(德国石勒苏益格-荷尔斯泰因)成立。自 2018 年以来,美国公司 PerkinElmer, Inc. 一直是 EUROIMMUN 的唯一股东。 PerkinElmer 是医疗和生物技术领域的国际领导者。该公司总部位于沃尔瑟姆(马萨诸塞州),在全球拥有 14,000 名员工。凭借其创新的测试系统、成像和 IT 系统,它在诊断、医学研究以及环境和食品分析方面提供了广泛的专业知识。 PerkinElmer, Inc. 在标准普尔 500 指数中上市。
EUROIMMUN 最初的开创性成就之一是 1983 年 BIOCHIP 的开发。今天,该公司使用几乎完全自动化的 BIOCHIP 碎裂和生产机器,这些机器是内部设计和生产的,并在全球范围内使用。
此外,该公司拥有广泛的技术基础,它已利用该基础来刺激和促进医学实验室诊断的根本性新发展。例如设计者抗原的分子生物学合成、基于计算机的免疫荧光显微镜 (CAIFM) 以及用于识别基因多态性和病原体的多参数微阵列的开发。
高专业能力和继续教育对于 EUROIMMUN 产品的使用和分销至关重要。 EUROIMMUN 学院每年接待来自 100 多个国家的 1000 多名客户进行科学培训。此外,在一些国家设有培训实验室。此外,隶属于 EUROIMMUN 的经认可的质量评估研究所提供质量评估计划,以帮助保持外部实验室的高质量标准。
价格: 0.00

As one of   the leading manufacturers of medical laboratory diagnostics worldwide,   EUROIMMUN stands for innovation. More than 3,200 employees in 17 countries   develop, produce and sell test systems to support the diagnosis of diseases,   as well as software and automation solutions for the performance and evaluation   of these tests. Laboratories in over 140 countries use EUROIMMUN products for   the diagnosis of autoimmune and infectious diseases as well as allergies, and   to perform genetic analyses.

   

The company   was founded in 1987 from the University of Lübeck (Schleswig-Holstein, Germany). Since 2018, the US American   company PerkinElmer, Inc. has been the sole shareholder of EUROIMMUN.   PerkinElmer is an international leader in medical and biotechnology. The   company, which has its headquarters in Waltham (Massachusetts), has 14,000   employees worldwide. With its innovative test systems, imaging and IT   systems, it offers an extensive expertise in diagnostics, medical research   and environmental and food analysis. PerkinElmer, Inc. is listed on the   S&P-500 Index.

Among the   initial pioneering achievements of EUROIMMUN was the development of BIOCHIPs   in 1983. Today, the company uses virtually fully automated BIOCHIP   fragmentation and production machines which are designed and produced   in-house and are in use worldwide.

Furthermore,   the company commands a broad technology base, which it has drawn on to   stimulate and promote fundamental new developments in medical laboratory   diagnostics. Examples are the molecular biological synthesis of designer   antigens, the computer-based immunofluorescence microscopy (CAIFM) and the   development of multiparameter microarrays for the identification of gene   polymorphisms and pathogens.

   

High professional competence and continuing education are essential in the use and distribution of EUROIMMUN products.

The EUROIMMUN Academy receives more than 1000 customers from over 100 countries for scientific trainings every year. Moreover, there are training laboratories in several countries. Furthermore, the accredited Institute for Quality Assessment affiliated to EUROIMMUN offers quality assessment schemes to help to maintain a high quality standard in external laboratories.